SAN FRANCISCO, October 21, 2015 /PRNewswire/ --

The global biopreservation market is expected to reach USD 9.34 billion by 2022, according to a new report by Grand View Research Inc. Increasing demand for novel bio-preservation techniques and constantly rising healthcare expenditure is expected to boost the market growth over the forecast period. Adoption of in-house sample storage system by hospitals, biotechnology and pharmaceutical companies is one of the critical success factors for the growth of the industry over next seven years.

     (Logo: http://photos.prnewswire.com/prnh/20150105/723757)

Browse full research report with TOC on "Biopreservation Market Analysis By Product (Equipment, Media, Laboratory Information Management System), By Application (Regenerative Medicine, Bio-banking, Drug Discovery), By Cell Providers (CD34+, CD19+, MSC, iPSC, hESC, Tumor Cells) And Segment Forecasts To 2022" at: http://www.grandviewresearch.com/industry-analysis/biopreservation-market                                                                                        

Additionally, increasing R&D investments by various research organizations and companies to enhance their capabilities to render efficient and effective products & services is a high impact rendering driver expected to boost bio-preservation market growth. Furthermore, as a consequence of technological advancements such as introduction of virtual bio-banks, bio-preservation is witnessing increased application in end-use hence boosting the growth of bio-preservation market.

Further key findings from the report suggest: 

• Equipment dominated the overall product segment in 2014, with the revenue share of over 80%. Key factors attributing to its large share include rising demand of bio-banks coupled with high cost for preservation of bio-specimens.  
• Media, which encompasses pre-formulated and home-brew media is expected to witness high growth over the forecast period as a consequence of their wide usage in regenerative medicines.
• Bio-banking dominated was the key application segment of bio-preservation in 2014, with lucrative market share owing to increasing number of organ and tissue transplantations, high patient awareness levels and rise in healthcare expenditure.
• Regenerative medicine is estimated to grow at a rate of over 18% as a result of huge investments made by government, and non government organizations in the field of regenerative cell therapy research.
• Tumor cells held the largest share in volume terms in 2014, owing to their wide applications in research & development, diagnosis, and treatment of highly prevalent cancer.
• North America dominated the overall industry in 2014 with over 45% revenue share majorly due to favorable government regulations in North America which are supporting the ethical usage and sharing of biological samples.
• Asia Pacific is expected to grow at substantial rate during the forecast period as a consequence of high unmet needs amongst the population in the region coupled with constantly improving healthcare infrastructure as a result of government initiatives such as Make In India.
• Key players of the bio-preservation market include BioCision, Biomatrica, BioLife Solutions Inc., Chart MVE Biomedical, LabVantage Solutions Inc., Atlanta Biologicals, Panasonic Biomedical, Thermo Fisher Scientific Inc. and Qiagen. These companies are involved in various developmental strategies such as mergers and acquisitions to sustain their market share.

Grand View Research has segmented the global biopreservation market on the basis of products, application, cell providers and region:

• Biopreservation Product Outlook (Revenue, USD Billion, 2012 - 2022) 
  • Equipment
    • Freezers
    • Refrigerators
    • Consumables
      • Vials
      • Straws
      • Microtiter Plates
      • Bags
    • Liquid Nitrogen
  • Media
    • Pre-formulated
    • Home-brew
  • Laboratory Information Management System (LIMS)
• Biopreservation Application Outlook (Revenue, USD Billion, 2012 - 2022) 
  • Regenerative Medicine
    • Cell therapy
    • Gene therapy
    • Others
  • Bio-banking
    • Human eggs
    • Human sperms
    • Veterinary IVF
  • Drug Discovery
• Biopreservation Cell Providers Outlook (Volume, Number of Units, 2012 - 2022) 
  • CD34+
  • CD19+
  • MSC
  • iPSC
  • hESC
  • Tumor Cells
  • Others
• Biopreservation Market Regional Outlook (Revenue, USD Billion, 2012 - 2022) 
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Browse related reports by Grand View Research: 

• In-Vitro Fertilization Market - http://www.grandviewresearch.com/industry-analysis/in-vitro-fertilization-market  

• Clinical Diagnostics Market - http://www.grandviewresearch.com/industry-analysis/clinical-diagnostics-market  

• Recombinant DNA Technology Market - http://www.grandviewresearch.com/industry-analysis/recombinant-dna-technology-market  

• Epigenetics Drugs and Diagnostic Technologies Market - http://www.grandviewresearch.com/industry-analysis/epigenetics-drugs-and-diagnostic-technologies-market                                                                                                                                                                                              

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Read Our Blogs - mediafound.org, dniamericas.org    

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email:sales@grandviewresearch.com
Web: http://www.grandviewresearch.com  

SOURCE Grand View Research, Inc.